Sign In
test

Ernest Verrico

Elmind Capital, Lp

Assets Managed
$352.219M
Holdings
34
Last Quarter
2026 - Q1
Filed Date
1mo 6d ago
Growth Rate
3.95%(2Q avg: 1.98%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Elmind Capital, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 34 positions.

Assets under management

The assets under management (AUM) of Elmind Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 352.219M in assets, with a quarterly growth rate of 3.95% and a 2-quarter average growth rate of 1.98%. The portfolio is managed by Ernest Verrico, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
COGT
Cogent Biosciences Inc
Recent Activity
12.8%
$45.062M
1.171M shares@ $38.5 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
12.31%
$43.333M
1.855M shares@ $23.36 avg price
CLDX
Celldex Therapeutics Inc
Recent Activity
7.79%
$27.438M
865,000 shares@ $31.72 avg price
CTMX
Cytomx Therapeutics Inc
Recent Activity
Increased 550%
6.08%
$21.385M
4.55M shares@ $4.7 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
Increased 27.46%
5.84%
$20.559M
1.021M shares@ $20.13 avg price
CGON
Cg Oncology Inc
Recent Activity
Decreased -40.75%
5.61%
$19.749M
291,800 shares@ $67.68 avg price
VERA
Vera Therapeutics Inc
Recent Activity
5.52%
$19.411M
482,500 shares@ $40.23 avg price
PCVX
Vaxcyte Inc
Recent Activity
Increased 8.58%
5.23%
$18.392M
316,500 shares@ $58.11 avg price
PHVS
Pharvaris Nv
Recent Activity
3.82%
$13.44M
475,750 shares@ $28.26 avg price
TYRA
Tyra Biosciences Inc
Recent Activity
3.81%
$13.405M
350,000 shares@ $38.3 avg price

1-10 of 34